After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. The Settlement Program will settle the claims of thousands of qualified claimants who suffered a heart attack, ischemic stroke, or sudden cardiac death resulting from Vioxx. The settlement funds will be allocated among thousands of qualifying claims based upon an evaluation of each Qualifying Claimant's medical records by a Claims Administrator.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Merck & Co. Inc. (MRK)
Merck & Co. Inc. is a large pharmaceutical company.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.